. | . | . | . | Stimulus . | . | . | |
---|---|---|---|---|---|---|---|
Response . | Change . | Protocol . | Time of (maximum) response . | Mechanical . | Metabolic . | Reference . | |
Second messengers | |||||||
JNK phosphorylation | Eightfold | 30 min treadmill, 5 mmol l-1 lactate | 4-30 min post exercise | con/ecc | Lactate | 5 | |
JNK kinase activity | 5.9-fold | 60 min ergometer, 70%V̇O2max | <10 min post-exercise | con | 2 | ||
JNK kinase activity | 3.5- to 15.4-fold | Maximal knee extension, 10 sets, 10 repetitions | <10 min post-exercise | ecc>con | 3 | ||
ERK phosphorylation | Eightfold | 60 min ergometer, marathon | <10 min post-exercise | con | 1, 14 | ||
p38 phosphorylation | 4.4-fold | Marathon 3-4.5 h | con/ecc | 14 | |||
α2-AMPK kinase activity | 3-4-fold | 60 min ergometer, 70 %V̇O2max | <10 min post-exercise | Lactate | 13 | ||
Immediate early genes | |||||||
c-fos, fosB, fra-1, c-jun, junB, junD mRNA | 3- to 20-fold | 30 min treadmill, at aerobic threshold, 5 mmol l-1 lactate | 4-30 min post-exercise | con/ecc | Lactate | 9 | |
c-jun mRNA | 1.8-fold | 60 min ergometer, 70 % Wmax | <10 min post-exercise | con | Lactate | 2 | |
HSP-70 mRNA | Fourfold | 30 min treadmill, aerobic threshold | 4 min to 3 h post-exercise | con/ecc | Lactate | 8 | |
VEGF mRNA | 2.1-fold | 45 min knee extensor | 30 min post-exercise | con | Lactate | 4 | |
VEGF mRNA | 7- to 17-fold | 5 min warm-up, max. test (50 % max. work rate) | 1 h post-exercise | con | Normoxia/PCO2 | 10 | |
Late genes | |||||||
LPL, PDK4, HKII, UCP-2, HO-1 transcription | 2- to 4-fold | 4 h ergometer, 50-60 %V̇O2max | 1-2 h post-exercise | con | 6 | ||
LPL, CPTI, HKII, GYS, PDK4, UCP-3, HO-1mRNA | 2- to 5-fold | 60-90 min ergometer, 70% 2 min maxr, fifth day of training | > 1 h mRNA post-exercise | con | 6 | ||
LPL mRNA | 1.3-fold | 60-90 min ergometer, 55-70 % peak oxygen, fifth day of training | 4 h post-exercise | con | 11 | ||
Chronic events | |||||||
CPT I mRNA | Twofold | 60-90 min ergometer per day for 4 days, 70 % 2 min maxr | con | 6 | |||
MCAD mRNA | 1.5-fold | 5× per week 30 min ergometer at 67 % relative Wmax | con | 12 | |||
PFK, HSP-70, COX4 mRNA | 1.5- to 2.5-fold | 5× per week 30 min ergometer at 67 % relative Wmax | con | Lactate | 12 | ||
VEGF mRNA | 1.5-fold | 5× per week 30 min ergometer at 58 % relative Wmax | con | Lactate+PCO2 | 12 | ||
HIF-1α mRNA | 1.8-fold | 5× per week 30 min ergometer at 52 % relative Wmax | con | PCO2 | 12 | ||
COX1, COX4, NADH6, 16S, SDH, fumarase mRNA | 1.5- to 1.9-fold | Years of systematic endurance training | 7 |
. | . | . | . | Stimulus . | . | . | |
---|---|---|---|---|---|---|---|
Response . | Change . | Protocol . | Time of (maximum) response . | Mechanical . | Metabolic . | Reference . | |
Second messengers | |||||||
JNK phosphorylation | Eightfold | 30 min treadmill, 5 mmol l-1 lactate | 4-30 min post exercise | con/ecc | Lactate | 5 | |
JNK kinase activity | 5.9-fold | 60 min ergometer, 70%V̇O2max | <10 min post-exercise | con | 2 | ||
JNK kinase activity | 3.5- to 15.4-fold | Maximal knee extension, 10 sets, 10 repetitions | <10 min post-exercise | ecc>con | 3 | ||
ERK phosphorylation | Eightfold | 60 min ergometer, marathon | <10 min post-exercise | con | 1, 14 | ||
p38 phosphorylation | 4.4-fold | Marathon 3-4.5 h | con/ecc | 14 | |||
α2-AMPK kinase activity | 3-4-fold | 60 min ergometer, 70 %V̇O2max | <10 min post-exercise | Lactate | 13 | ||
Immediate early genes | |||||||
c-fos, fosB, fra-1, c-jun, junB, junD mRNA | 3- to 20-fold | 30 min treadmill, at aerobic threshold, 5 mmol l-1 lactate | 4-30 min post-exercise | con/ecc | Lactate | 9 | |
c-jun mRNA | 1.8-fold | 60 min ergometer, 70 % Wmax | <10 min post-exercise | con | Lactate | 2 | |
HSP-70 mRNA | Fourfold | 30 min treadmill, aerobic threshold | 4 min to 3 h post-exercise | con/ecc | Lactate | 8 | |
VEGF mRNA | 2.1-fold | 45 min knee extensor | 30 min post-exercise | con | Lactate | 4 | |
VEGF mRNA | 7- to 17-fold | 5 min warm-up, max. test (50 % max. work rate) | 1 h post-exercise | con | Normoxia/PCO2 | 10 | |
Late genes | |||||||
LPL, PDK4, HKII, UCP-2, HO-1 transcription | 2- to 4-fold | 4 h ergometer, 50-60 %V̇O2max | 1-2 h post-exercise | con | 6 | ||
LPL, CPTI, HKII, GYS, PDK4, UCP-3, HO-1mRNA | 2- to 5-fold | 60-90 min ergometer, 70% 2 min maxr, fifth day of training | > 1 h mRNA post-exercise | con | 6 | ||
LPL mRNA | 1.3-fold | 60-90 min ergometer, 55-70 % peak oxygen, fifth day of training | 4 h post-exercise | con | 11 | ||
Chronic events | |||||||
CPT I mRNA | Twofold | 60-90 min ergometer per day for 4 days, 70 % 2 min maxr | con | 6 | |||
MCAD mRNA | 1.5-fold | 5× per week 30 min ergometer at 67 % relative Wmax | con | 12 | |||
PFK, HSP-70, COX4 mRNA | 1.5- to 2.5-fold | 5× per week 30 min ergometer at 67 % relative Wmax | con | Lactate | 12 | ||
VEGF mRNA | 1.5-fold | 5× per week 30 min ergometer at 58 % relative Wmax | con | Lactate+PCO2 | 12 | ||
HIF-1α mRNA | 1.8-fold | 5× per week 30 min ergometer at 52 % relative Wmax | con | PCO2 | 12 | ||
COX1, COX4, NADH6, 16S, SDH, fumarase mRNA | 1.5- to 1.9-fold | Years of systematic endurance training | 7 |
1, Aronson et al. (1997); 2,Aronson et al. (1998); 3,Boppart et al. (1999); 4,Gustafsson et al. (1999); 5,Heider et al. (1995); 6,Pilegaard et al. (2000); 7,Puntschart et al. (1995); 8,Puntschart et al. (1996); 9,Puntschart et al. (1998); 10,Richardson et al. (1999); 11,Seip et al. (1997); 12, Vogt et al. (2001); 13,Wojtaszewski et al. (2000);14, Yu et al. (2001); con,concentric exercise; ecc, eccentric exercise; Wmax,maximal power; V̇O2max, maximal rate of oxygen uptake; maxr, maximal resistance; PCO2, cellular oxygen partial pressure.